UCB Italy s.p.a. clinical trials

A country office of UCB S.A.

The registry lists 1 studies whose lead sponsor is UCB Italy s.p.a.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 15, 2017.

Status

Completed: 1

Phase

Phase 4: 1

Where

Italy: 1

Registry sponsor names on this page

UCB Italy s.p.a.1 study

Something wrong with this grouping? Tell us on the UCB S.A. page.

Studies

Recruiting first, then most recently updated. Showing 1 of 1. All UCB S.A. studies →

Open Label Study to Assess the Predictability of Early Response to Certolizumab Pegol in Patients With Rheumatoid ArthritisCompletedNCT01443364Phase 4
Sponsor listed in the registry: UCB Italy s.p.a.